🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.00
-1.35 (-4.60%)
Nov 20, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
151.22345.67301.54378.48401.2417.12
Trading Asset Securities
----1.311.28
Cash & Short-Term Investments
178.22345.67301.54378.48402.51418.41
Cash Growth
-32.30%14.63%-20.33%-5.97%-3.80%56.21%
Accounts Receivable
425.93363.56423.08374.67386.71350.44
Other Receivables
0.190.980.121.30.150.4
Receivables
426.12364.54423.2375.97386.86350.84
Inventory
760731.56709.06762.62827.58701.44
Prepaid Expenses
117.4224.2320.3620.6123.3820.71
Other Current Assets
1.0426.611.83---
Total Current Assets
1,4831,4931,4561,5381,6401,491
Property, Plant & Equipment
2,1862,0892,1051,8671,6021,682
Long-Term Investments
92.92114.81129.12152.18118.9750.29
Other Intangible Assets
13.815.284.345.23.875.21
Long-Term Deferred Tax Assets
27.1125.3922.0239.3627.0729.84
Other Long-Term Assets
71.0796.6895.99255.08192.61169.83
Total Assets
3,8733,8233,8133,8563,5853,429

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
219.66211.55210.38166.8254.3224.34
Accrued Expenses
-122.32113.99100.61--
Short-Term Debt
420460450580370479.99
Current Portion of Long-Term Debt
39.278.9319.8612.512.512.5
Current Portion of Leases
0.470.370.750.491.051.26
Current Income Taxes Payable
8.0222.6411.782.757.0146.61
Current Unearned Revenue
102.97121.42123.9127.97142.49131.55
Other Current Liabilities
255.93117.55212.17291.63203.04176.7
Total Current Liabilities
1,0461,0651,1431,2831,0401,073
Long-Term Debt
299.95186.39167.26112.52537.5
Long-Term Leases
3.02-0.370.070.591.55
Pension & Post-Retirement Benefits
-51.7550.0153.715353.36
Long-Term Deferred Tax Liabilities
0.140.680.35-1.20.26
Other Long-Term Liabilities
83.1230.130.130.153.3323.06
Total Liabilities
1,4331,3341,3911,4791,1741,189

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,0101,0101,0101,0101,0101,010
Additional Paid-In Capital
164.22245.01325.8426.79457.09482.34
Retained Earnings
1,2631,2291,086940.46944.03748.02
Comprehensive Income & Other
-0.04-0.04-0.04-0.030.02-0.04
Total Common Equity
2,4372,4842,4222,3772,4112,240
Minority Interest
3.875.53----
Shareholders' Equity
2,4412,4902,4222,3772,4112,240
Total Liabilities & Equity
3,8733,8233,8133,8563,5853,429

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
762.72655.69638.23705.56409.13532.81
Net Cash (Debt)
-584.5-310.02-336.69-327.08-6.62-114.4
Net Cash Growth
------
Net Cash Per Share
-5.76-3.06-3.33-3.23-0.07-1.13
Filing Date Shares Outstanding
101.94100.99100.99100.99100.99100.99
Total Common Shares Outstanding
101.94100.99100.99100.99100.99100.99
Working Capital
436.48427.82313.17254.99599.94418.44
Book Value Per Share
23.9124.6023.9823.5423.8722.18
Tangible Book Value
2,4232,4792,4182,3722,4072,235
Tangible Book Value Per Share
23.7724.5523.9423.4923.8422.13
Land
-757.96767.41573.57247.28247.28
Buildings
-1,2231,2321,1341,1201,111
Machinery
-2,6982,5862,5062,4312,359
Construction In Progress
-10956.5426.7936.5341.57